Chemours turns to euros as it reprices $1.5bn term loan 'B'

Chemours, the listed US chemicals firm spun out of DuPont in 2015, held a lender call on Monday afternoon for a $350m-equivalent euro term loan to repay some of its existing dollar loan.

  • By Max Bower
  • 20 Mar 2017

The Wilmington, Delaware-based firm also wants to reprice its $1.5bn seven year term loan ‘B’, signed in 2015, after its $3bn spin-out from DuPont. The original margin was 300bp with a 0.75% Libor floor.

Price talk for the dollar repricing of 250bp with a 0% floor was released after ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 17 Jul 2017
1 BNP Paribas 10,842.91 57 6.39%
2 Goldman Sachs 10,585.91 37 6.24%
3 JPMorgan 9,783.62 40 5.77%
4 Deutsche Bank 8,799.90 51 5.19%
5 Credit Agricole CIB 8,327.15 45 4.91%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • 18 Jul 2017
1 JPMorgan 5,095.99 40 8.35%
2 Goldman Sachs 4,273.93 33 7.01%
3 Deutsche Bank 4,159.17 38 6.82%
4 Credit Suisse 3,915.70 42 6.42%
5 Barclays 3,740.83 31 6.13%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 18 Jul 2017
1 JPMorgan 21,273.54 160 11.24%
2 Citi 17,526.81 129 9.26%
3 Bank of America Merrill Lynch 15,607.84 134 8.24%
4 Goldman Sachs 13,221.26 95 6.98%
5 Barclays 13,207.72 84 6.98%